PureTech (PRTC) Q1 2025 Earnings Call Summary
PureTech (PRTC) reported strong Q1 2025 performance with 6% constant currency revenue growth, driven by its pharmaceuticals division and premium intraocular lenses. The company highlighted its robust pipeline and strategic focus on selling excellence and operational efficiency.
Tickers: $PRTC
Topics: Earnings Call Management Commentary Pipeline Development Product Launches Revenue Growth